7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of MichiganNuminus Wellness Reaches Major Milestone With MAPS Sponsored MDMA StudyNuminus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSDPsyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical TrialTryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary FormulationsPsyched Wellness Commences Next Pre-Clinical Study on AME-1Atai Life Sciences Is Setting The Standard For Psychedelic Drug DevelopmentCybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory BoardEntheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave.Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004Rritual Superfoods Ready to Launch Amazon Store in USAAtai Life Sciences Is Setting The Stage For The Largest IPO The Psychedelics Sector Has Seen To DateEntheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available fMajor U.S. States Are Taking A Serious Look At Decriminalizing Psychedelic Compounds For The Treatment Of Mental Illness

Join the top platform for cannabis stock analysis.

Premium Newsletter & Content Feed

A daily stream of market moving news, company announcements and earnings announcements keeps your finger on the pulse of the market.

Priority Access to Our Analysts

Have an urgent question on a stock, company, or trade? As a premium member, you have direct, priority access to our team.

Member’s Dashboard

Everything you need in one convenient, sleek dashboard. Access your premium news, market data, exclusive Mushroomstocks reports, and more.

What Members are Saying:

  • “In the crazy world of cannabis stocks, I’ve found Techincal420’s advice knowledge and invaluable. Techincal420’s team does a great job researching companies which helps me concentrate on the right companies. ” PAUL
  • “I read about technical 420 a couple months ago on a CNBC article… I was thrilled about Michael Berger’s idea of covering this seed-stage market since day one. Personally, I think the article undersold the value that Michael provides his subscribers. Michael is able to find value in an opaque market and rely that information in a way that is easy to understand and act on. If you want to invest in cannabis stocks, Mushroomstocks is the place to go!” ERALDO
  • “I want to thank Michael Berger for creating this resource. Similarly, I asked my Raymond James investment advisor about resources for investing in the Cannabis industry. I was given this website, among others. Out of all the resources I was given, Mushroomstocks without a doubt provides the most thorough and non-biased information on marijuana stocks and the cannabis industry. ” KAI
  • “Michael is a wiz when it comes to the stock market. I came to Mushroomstocks without any investment experience and Michael essentially tutored me and explained how everything works and why it works in the fashion it does. When it comes to the marijuana industry there is no one better. His cutting edge approach to this promising, yet opaque market is second to none. I would unquestionably recommend him to anyone who wants to learn about the marijuana stock industry.” NIMZJAB

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link